Although ST2-Fc treatment significantly decreased joint swelling and arthritis at early and intermediate time points compared to mice injected with an isotype control (Fig. 7k and Supplementary Fig. 6h), the significance of this protective effect was lost at the final time point (Fig. 7k). The gene discussed is IL1RL1; the disease is arthritic joint disease.